default author photo

Jiali Li

Government of the People's Republic of China - Medical Center of Hematology

Chongqing

China

SCHOLARLY PAPERS

2

DOWNLOADS

254

TOTAL CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Genomic Profiling of Plasma Circulating Tumor DNA Reveals Genetics and Residual Disease in Extranodal NK/T-Cell Lymphoma

Number of pages: 25 Posted: 22 Aug 2019
Jun Rao, Wei Zhang, Qiong Li, Jingkang Xiong, Lidan Zhu, Jiali Li, Jia Liu, Ting Chen, Han Yao, Qing Wen, Yunjing Zeng, Li Gao, Lei Gao, Cheng Zhang, Peiyan Kong, Yao Liu and Xi Zhang
Government of the People's Republic of China - Department of Hematology, Government of the People's Republic of China - Department of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology and Government of the People's Republic of China - Medical Center of Hematology
Downloads 135 (544,251)

Abstract:

Loading...

ENKTL, Circulating tumor DNA, mutation allele frequency, minimal residual disease, prognosis

2.

Tandem Autologous Hematopoietic Stem Cell Transplantation for Treatment of Adult T-Cell Lymphoblastic Lymphoma: A Multiple Center Prospective Study in Southwestern China

Number of pages: 31 Posted: 16 Jan 2019
Yao Liu, Jun Rao, Jiali Li, Qin Wen, Sanbin Wang, Shifeng Lou, Tonghua Yang, Bin Li, Lei Gao, Cheng Zhang, Peiyan Kong, Li Gao, Maihong Wang, Lidan Zhu, Xixi Xiang, Sha Zhou, Xue Liu, Xiangui Peng, Jiangfan Zhong and Xi Zhang
Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Department of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Department of Hematology, Government of the People's Republic of China - General Hospital of Kunming Military Region, Chongqing Medical University - Second Affiliated Hospital, Government of the People's Republic of China - Yunan Provincial People’s Hospital, Second Yunnan Provincial People's Hospital, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Department of Hematology, Government of the People's Republic of China - Medical Center of Hematology, Government of the People's Republic of China - Department of Hematology, Government of the People's Republic of China - Department of Hematology, Government of the People's Republic of China - Department of Hematology, Government of the People's Republic of China - Department of Hematology, Government of the People's Republic of China - Department of Hematology and Government of the People's Republic of China - Medical Center of Hematology
Downloads 119 (600,462)

Abstract:

Loading...

T-cell lymphoblastic lymphoma, autologous hematopoietic stem cell transplantation, progression-free survival, progression/relapse rate, overall survival